Total Payments
$651.30
2024 Payments
$19.74
Companies
10
Transactions
13
Medicare Patients
1,313
Medicare Billing
$621,708
Payment Breakdown by Category
Food & Beverage$532.73 (81.8%)
Education$103.07 (15.8%)
Other$15.50 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $532.73 | 10 | 81.8% |
| Education | $103.07 | 2 | 15.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.50 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $172.55 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $132.91 | 2 | $0 (2023) |
| GENZYME CORPORATION | $112.62 | 1 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $99.99 | 1 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $52.75 | 2 | $0 (2020) |
| Baxter Healthcare | $31.32 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.74 | 1 | $0 (2024) |
| United Therapeutics Corporation | $15.50 | 1 | $0 (2018) |
| Smith+Nephew, Inc. | $10.84 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.74 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19.74) |
| 2023 | $135.99 | 3 | AstraZeneca Pharmaceuticals LP ($132.91) |
| 2022 | $31.32 | 1 | Baxter Healthcare ($31.32) |
| 2020 | $41.41 | 1 | Otsuka America Pharmaceutical, Inc. ($41.41) |
| 2019 | $306.99 | 4 | GENZYME CORPORATION ($112.62) |
| 2018 | $115.85 | 3 | Relypsa, Inc. ($89.01) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: DIABETES | ||||||
| 10/19/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2022 | Baxter Healthcare | Renal - PD (Device) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: Renal | ||||||
| 01/30/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $41.41 | General |
| Category: NEPHROLOGY | ||||||
| 12/13/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/07/2019 | GENZYME CORPORATION | FABRAZYME (Drug) | Food and Beverage | In-kind items and services | $112.62 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 10/21/2019 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Pharma Product | ||||||
| 03/28/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $83.54 | General |
| Category: Hyperkalemia | ||||||
| 08/09/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $89.01 | General |
| Category: Hyperkalemia | ||||||
| 07/23/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: NEPHROLOGY | ||||||
| 04/30/2018 | United Therapeutics Corporation | NONE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $15.50 | General |
| Category: NON-BRANDEDDISEASE STATE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 272 | 772 | $231,200 | $122,849 |
| 2022 | 10 | 290 | 1,061 | $264,159 | $144,122 |
| 2021 | 10 | 349 | 1,326 | $327,180 | $181,295 |
| 2020 | 10 | 402 | 1,650 | $366,812 | $173,442 |
Total Patients
1,313
Total Services
4,809
Medicare Billing
$621,708
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 200 | $100,000 | $51,836 | 51.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 17 | 143 | $64,350 | $31,117 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 76 | $15,200 | $9,134 | 60.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 62 | $13,950 | $8,005 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 84 | $12,600 | $7,520 | 59.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 76 | $9,500 | $6,731 | 70.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 17 | 106 | $10,600 | $5,648 | 53.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $5,000 | $2,858 | 57.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 40 | 272 | $136,000 | $73,022 | 53.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 17 | 145 | $65,250 | $32,445 | 49.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 72 | $13,425 | $9,218 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 86 | $12,900 | $7,281 | 56.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 39 | $8,775 | $5,573 | 63.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 70 | $8,750 | $5,252 | 60.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 20 | 83 | $8,300 | $4,507 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $5,200 | $3,235 | 62.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $2,475 | $1,808 | 73.0% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 14 | 257 | $3,084 | $1,780 | 57.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 48 | 367 | $183,500 | $97,612 | 53.2% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 18 | 140 | $63,000 | $31,759 | 50.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 81 | $14,050 | $10,775 | 76.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 88 | $12,960 | $8,513 | 65.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 105 | $13,125 | $8,208 | 62.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 31 | 140 | $14,000 | $7,804 | 55.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 47 | 49 | $11,025 | $7,420 | 67.3% |
About Adel Saleh, M D
Adel Saleh, M D is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720033038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Adel Saleh, M D has received a total of $651.30 in payments from pharmaceutical and medical device companies, with $19.74 received in 2024. These payments were reported across 13 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($532.73).
As a Medicare-enrolled provider, Saleh has provided services to 1,313 Medicare beneficiaries, totaling 4,809 services with total Medicare billing of $621,708. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Nashville, TN
- Active Since 05/24/2006
- Last Updated 08/22/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720033038
Products in Payments
- Veltassa (Drug) $172.55
- FARXIGA (Drug) $132.91
- FABRAZYME (Drug) $112.62
- ACTHAR (Biological) $99.99
- JYNARQUE (Drug) $52.75
- Renal - PD (Device) $31.32
- JARDIANCE (Drug) $19.74
- NONE (Drug) $15.50
- Santyl (Drug) $10.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Nephrology $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Nephrology $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Nephrology $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Nephrology $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Nephrology $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757
Nephrology $33,757